CMS's MFN Model Rule for Medicare Part B Drug Reimbursement Enjoined
Federal District Courts Enjoin CMS’s Most Favored Nation Model Rule for Medicare Part B Drug Reimbursement Saturday, January 9, 2021 At a time when prescription drug costs have been increasingly burdensome for Medicare beneficiaries, and the American taxpayer, the Centers for Medicare and Medicaid Services (“CMS”) issued an interim final rule with comment period on November 27, 2020,[i] explicitly recognizing, as a basis for the rule, “[i]ncreases in drug prices” that “far exceed prices in other countries.”[ii] and establishing a new reimbursement methodology for th...
Source: natlawreview.com